Baldoni John - Insider Non-Derivative Transactions at MiNK Therapeutics, Inc. (INKT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 1, 2023, Baldoni John's relationship to MiNK Therapeutics, Inc. (INKT) is Director, and currently has 41,193 shares of Common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other INKT insiders.
Data Source: SEC.
Baldoni John - Insider Non-Derivative Transactions of INKT Common stock
Baldoni John - Insider Non-Derivative Transactions at INKT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 2, 2023 | Acquisition -- (Common stock) | 9846 | 1.46 | 41193 |
| Jun 2, 2023 | Acquisition -- (Common stock) | 8168 | 1.76 | 31528 |
| Mar 2, 2023 | Acquisition -- (Common stock) | 6878 | 2.09 | 23360 |